Eiger BioPharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Eiger BioPharmaceuticals's estimated annual revenue is currently $20.6M per year.
- Eiger BioPharmaceuticals's estimated revenue per employee is $155,000
Employee Data
- Eiger BioPharmaceuticals has 133 Employees.
- Eiger BioPharmaceuticals grew their employee count by 5% last year.
Eiger BioPharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Consulting Chief Financial Officer | Reveal Email/Phone |
2 | VP Clinical Operations | Reveal Email/Phone |
3 | Head Regulatory Affairs CMC | Reveal Email/Phone |
4 | VP, Clinical Strategy | Reveal Email/Phone |
5 | SVP, Clinical & Development Operations | Reveal Email/Phone |
6 | Senior Director, Operations | Reveal Email/Phone |
7 | Chief Business Officer | Reveal Email/Phone |
8 | Sr Director PV Operations | Reveal Email/Phone |
9 | Executive Director, Regulatory Affairs | Reveal Email/Phone |
10 | Associate Director, Quality Assurance | Reveal Email/Phone |
Eiger BioPharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.3M | 21 | 31% | N/A | N/A |
What Is Eiger BioPharmaceuticals?
Eiger Inc is a research company based out of 55 2Nd St, San Francisco, CA, United States.
keywords:N/A
N/A
Total Funding
133
Number of Employees
$20.6M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Eiger BioPharmaceuticals News
2022-04-17 - Eiger BioPharmaceuticals Strengthens Leadership Team with ...
Eiger BioPharmaceuticals Strengthens Leadership Team with New Executive Appointments. Published: Apr 18, 2022. Chris Kurtz Appointed Chief Technical Officer...
2022-04-17 - Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Short Interest ...
Eiger BioPharmaceuticals, Inc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted...
2022-04-06 - Eiger Biopharmaceuticals: Value Inflection For Lead Asset In HDV Infection
On The Horizon
Eiger Biopharmaceuticals: Value Inflection For Lead Asset In HDV Infection On The Horizon. Apr. 06, 2022 2:48 PM ETEiger BioPharmaceuticals, Inc. (EIGR)5...
Other Companies in San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $18.6M | 133 | -17% | $17M |
#2 | $19.3M | 133 | 3% | N/A |
#3 | $20M | 133 | 0% | N/A |
#4 | $17.3M | 133 | 9% | $50M |
#5 | $18.6M | 133 | -5% | $139.8M |